Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01822197 · ClinicalTrials.gov registry record · NA

Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients

A NA study of Depression and Cystic Fibrosis, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01822197 is a NA study of Depression and Cystic Fibrosis that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 30 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01822197, a NA study of Depression and Cystic Fibrosis, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether bright light phototherapy can improve depressive symptoms in hospitalized patients with cystic fibrosis (CF) with subsequent effects on quality of life and illness recovery. It is hypothesized that phototherapy will improve depressive symptoms and decrease length of stay in depressed patients with CF who are hospitalized.

Interventions

  • DEVICE Phototherapy

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-03
Est. Completion 2015-06
Phase NA

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT01822197

The ClinicalTrials.gov registry entry for NCT01822197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Phototherapy is the first listed.

NCT01822197 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01822197 about?

NCT01822197 is a clinical study titled "Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients". The purpose of this study is to determine whether bright light phototherapy can improve depressive symptoms in hospitalized patients with cystic fibrosis (CF) with subsequent effects on quality of life and illness recovery. It is hypothesized that phototherapy will improve depressive symptoms and de...

What is the current status of trial NCT01822197?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-03. Estimated completion is 2015-06.

What conditions does trial NCT01822197 study?

This clinical trial studies the following conditions: Depression, Cystic Fibrosis.

What interventions are being tested in trial NCT01822197?

The interventions under investigation include: Phototherapy (DEVICE).

Who is sponsoring clinical trial NCT01822197?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01822197 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.